Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Rocket Pharmaceuticals Inc., 3 years.
Rocket Pharmaceuticals Inc.
Director
Pharvaris N.V.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rocket Pharmaceuticals Inc. June 18, 202597.3%
-
Rocket Pharmaceuticals Inc. June 13, 202494.0%
-
Rocket Pharmaceuticals Inc. June 22, 202391.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Pharvaris N.V. | Option exercise | +35,000 | $14.39 | $503,650 |
| Sep 17, 2026 | Pharvaris N.V. | Option exercise | +17,500 | $18.14 | $317,450 |
| Sep 17, 2026 | Pharvaris N.V. | Open-market sale | −52,500 | $37.89 | $1,989,409 |
| May 20, 2026 | Pharvaris N.V. | Option exercise | +10,000 | $8.05 | $80,500 |
| May 20, 2026 | Pharvaris N.V. | Open-market sale | −10,000 | $29.32 | $293,200 |
| Jan 2, 2026 | Rocket Pharmaceuticals Inc. | Open-market purchase | +10,000 | $3.44 | $34,400 |
| Aug 27, 2025 | Rocket Pharmaceuticals Inc. | Open-market purchase | +10,000 | $3.41 | $34,100 |
| Jun 18, 2025 | Rocket Pharmaceuticals Inc. | Grant or award | +30,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.